Therapeutic Indications

Cangrelor is indicated for:

Percutaneous transluminal coronary angioplasty

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous

Contraindications

Active ingredient Cangrelor is contraindicated in the following cases:

No gender/age discrimination

at least one of
Bleeding

Transient cerebral ischaemic attacks and related syndromes